Cholangitis: Clinical Trials

9 trials for Cholangitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 terminated. 9 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Terminated 9
Phase 32Terminated 2
Phase 11Terminated 1

Follow Cholangitis: new trials by email Literature Review of Cholangitis trials Research Report on Cholangitis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis
Ritivixibat - Primary Sclerosing Cholangitis
Phase 2TerminatedAlbireo, an Ipsen Company182023-01-092026-05-04
Vancomycin for Primary Sclerosing Cholangitis
Vancomycin, Placebo - Primary Sclerosing Cholangitis
Phase 2 / Phase 3TerminatedElizabeth Carey1022020-01-232026-10-21
A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC
Seladelpar, Placebo to match Seladelpar - Primary Sclerosing Cholangitis
Phase 2TerminatedGilead Sciences12019-11-122025-01-16
An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis
All-trans retinoic acid - Cholangitis, Sclerosing
Phase 2TerminatedYale University22018-05-292021-08-09
A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC)
DUR-928 - Primary Sclerosing Cholangitis
Phase 2TerminatedDurect52018-01-222022-10-17
Haemodynamic Stability of Ketamine/Propofol Admixture "Ketofol" in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography
Ketamine / Propofol Admixture, Propofol - Pancreatitis, Cholangitis
Phase 2TerminatedAssiut University902015-07-012019-09-23
Pilot Study of Fenofibrate for PSC
fenofibrate - Primary Sclerosing Cholangitis
Phase 1 / Phase 2TerminatedUniversity of Miami82010-10-012018-02-06
Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)
Thalidomide - Primary Sclerosing Cholangitis
Phase 2TerminatedMayo Clinic12006-04-012012-02-27
Trial of High-dose Urso in Primary Sclerosing Cholangitis
Ursodeoxycholic Acid, Placebo - Primary Sclerosing Cholangitis
Phase 2 / Phase 3TerminatedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1502002-07-012021-05-03

Narrower conditions

Cholangitis, Sclerosing (8)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Digestive System Diseases (1)  ·  Pancreatitis (1)

Broader conditions

Bile Duct Diseases (8)  ·  Biliary Tract Diseases (8)  ·  Digestive System Diseases (8)  ·  Pancreatic Diseases (1)

Interventions

(2-methyl-4-(5-methyl-2-(4-trifluoromethyl-phenyl)-2H-(1,2,3)triazol-4-ylmethylsulfanyl)phenoxy)acetic acid (1)  ·  Fenofibrate (1)  ·  Ketamine (1)  ·  Propofol (1)  ·  Thalidomide (1)  ·  Tretinoin (1)  ·  Ursodeoxycholic Acid (1)  ·  Vancomycin (1)  ·  seladelpar (1)

Sponsors

Albireo, an Ipsen Company (1)  ·  Assiut University (1)  ·  Durect (1)  ·  Elizabeth Carey (1)  ·  Gilead Sciences (1)  ·  Mayo Clinic (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  University of Miami (1)  ·  Yale University (1)

Countries

United States (7)  ·  Poland (2)  ·  Canada (1)  ·  Egypt (1)  ·  France (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Alastair Smith, MD (1)  ·  Cynthia Levy, MD (1)  ·  Elizabeth Carey, MD (1)  ·  James Boyer, MD (1)  ·  Keith D Lindor, MD (1)  ·  Mohamed A Bakr, Prof. (1)

Results publications

PMID 19585548, PMID 42489629

NIH funding

2019 (1), R01DK056924 (1)